Synapse

← Transfusion Alternatives in Transfusion Medicine

Papers in Transfusion Alternatives in Transfusion Medicine

Page 2 · newest first

  1. Pegylated hemoglobins mechanisms to avoid vasoconstriction and maintain perfusionTransfusion Alternatives in Transfusion Medicine · 2007
  2. Resuscitation from hemorrhagic shock: recovery of oxygen carrying capacity or perfusion? Efficacy of new plasma expandersTransfusion Alternatives in Transfusion Medicine · 2007
  3. Blood viscosity modulates tissue perfusion – sometimes and somewhereTransfusion Alternatives in Transfusion Medicine · 2007
  4. Novel strategies for transporting cellular hemoglobin‐based oxygen carriers in the systemic circulationTransfusion Alternatives in Transfusion Medicine · 2007
  5. Solution to the problems of acellular hemoglobins by encapsulation and the intrinsic issues of hemoglobin vesicles as a molecular assemblyTransfusion Alternatives in Transfusion Medicine · 2007
  6. Editorial: Blood substitutes better than blood?Transfusion Alternatives in Transfusion Medicine · 2007
  7. The safety profile of Hemospan®: a new oxygen therapeutic designed using maleimide poly(ethylene) glycol conjugation to human hemoglobinTransfusion Alternatives in Transfusion Medicine · 2007
  8. Oxidation of hemoglobin: mechanisms of control in vitro and in vivoTransfusion Alternatives in Transfusion Medicine · 2007
  9. Perfluorocarbons as gas transporters for O2, NO, CO and volatile anestheticsTransfusion Alternatives in Transfusion Medicine · 2007
  10. Managing situations of acute blood loss with limited resourcesTransfusion Alternatives in Transfusion Medicine · 2007
  11. Clinical experience with intravenous ironTransfusion Alternatives in Transfusion Medicine · 2007
  12. Intravenous iron as a transfusion alternativeTransfusion Alternatives in Transfusion Medicine · 2007
  13. Hydroxyethyl starch solutions and their effect on the microcirculation and tissue oxygenation*Transfusion Alternatives in Transfusion Medicine · 2007
  14. Anemia management: intravenous iron can enable a reduction in blood transfusions – a benefit for patients and hematology wardsTransfusion Alternatives in Transfusion Medicine · 2007
  15. The starch family: are they all equal? Pharmacokinetics and pharmacodynamics of hydroxyethyl starchesTransfusion Alternatives in Transfusion Medicine · 2007
  16. Effects of hydroxyethyl starches on hemostasisTransfusion Alternatives in Transfusion Medicine · 2007
  17. Saline versus balanced hydroxyethyl starch: does it matter?Transfusion Alternatives in Transfusion Medicine · 2007
  18. Blood transfusion: challenges and limitationsTransfusion Alternatives in Transfusion Medicine · 2007
  19. Hydroxyethyl starch and renal dysfunctionTransfusion Alternatives in Transfusion Medicine · 2007
  20. The cost‐effectiveness of autologous transfusion alternatives: an update and reappraisalTransfusion Alternatives in Transfusion Medicine · 2007
  21. Preoperative intravenous iron administration corrects anemia and reduces transfusion requirement in women undergoing abdominal hysterectomyTransfusion Alternatives in Transfusion Medicine · 2007
  22. Anaphylactoid reaction to Haemaccel® infusion and contact sensitization to Opticlude® orthoptic eye patches: a case reportTransfusion Alternatives in Transfusion Medicine · 2007
  23. Bolus intraperitoneal iron versus intravenous iron in peritoneal dialysis patients: a prospective studyTransfusion Alternatives in Transfusion Medicine · 2007
  24. Speaker abstractsTransfusion Alternatives in Transfusion Medicine · 2007
  25. Postoperative care in fast‐track rehabilitation for elective colonic surgeryTransfusion Alternatives in Transfusion Medicine · 2007
  26. Tolerability and efficacy of parenteral iron therapy in hemodialysis patients, a comparison of preparationsTransfusion Alternatives in Transfusion Medicine · 2007
  27. Adverse events associated with intravenous iron infusion (low‐molecular‐weight iron dextran and iron sucrose): a systematic reviewTransfusion Alternatives in Transfusion Medicine · 2007
  28. Anesthesia and intraoperative support of homeostasis in fast‐track rehabilitation for elective colonic surgeryTransfusion Alternatives in Transfusion Medicine · 2007
  29. Results of fast‐track rehabilitation in elective colonic surgeryTransfusion Alternatives in Transfusion Medicine · 2007
  30. ‘Fast‐track’ protocols in colorectal surgeryTransfusion Alternatives in Transfusion Medicine · 2007
  31. Preoperative patient preparation for enhanced recovery after surgeryTransfusion Alternatives in Transfusion Medicine · 2007
  32. Intraoperative surgical considerations for enhanced recovery after elective colonic surgeryTransfusion Alternatives in Transfusion Medicine · 2007
  33. Spanish consensus statement on alternatives to allogeneic transfusions: the ‘Seville document’Transfusion Alternatives in Transfusion Medicine · 2006
  34. The use of recombinant activated factor VII in pediatric coagulation disordersTransfusion Alternatives in Transfusion Medicine · 2006
  35. Role of recombinant activated factor VII as hemostatic support in orthopedic surgeryTransfusion Alternatives in Transfusion Medicine · 2006
  36. New anticoagulants and the management of their bleeding complicationsTransfusion Alternatives in Transfusion Medicine · 2006
  37. Recombinant activated factor VII for neurological and neurosurgical bleeding emergenciesTransfusion Alternatives in Transfusion Medicine · 2006
  38. Recombinant activated factor VII for trauma patientsTransfusion Alternatives in Transfusion Medicine · 2006
  39. Use of recombinant activated factor VII in the management of medical and surgical bleeding: a critical reviewTransfusion Alternatives in Transfusion Medicine · 2006
  40. Pathophysiology and management of dengue hemorrhagic feverTransfusion Alternatives in Transfusion Medicine · 2006
  41. New antithrombotics – pharmacologic profile and implications for anesthesia and surgeryTransfusion Alternatives in Transfusion Medicine · 2006
  42. Perioperative management of oral anticoagulationTransfusion Alternatives in Transfusion Medicine · 2006
  43. Consequences of coronary artery stenting for non‐cardiac surgeryTransfusion Alternatives in Transfusion Medicine · 2006
  44. A strategy for platelet transfusion in patients with alloantibodies to plateletsTransfusion Alternatives in Transfusion Medicine · 2006
  45. Alternatives to platelet transfusions in the management of platelet dysfunction or thrombocytopeniaTransfusion Alternatives in Transfusion Medicine · 2006
  46. Platelet biology – an overviewTransfusion Alternatives in Transfusion Medicine · 2006
  47. Comparison of two hydroxyethyl starch 200/0.5 formulations with regard to hemorheology, coagulation and elimination kineticsTransfusion Alternatives in Transfusion Medicine · 2006
  48. The assessment of platelet functionTransfusion Alternatives in Transfusion Medicine · 2006
  49. Current controversies about the indications for platelet transfusion with a focus on patients with hematological malignanciesTransfusion Alternatives in Transfusion Medicine · 2006
  50. Editorial: the art of platelet transfusionTransfusion Alternatives in Transfusion Medicine · 2006